MedTrace Logo

Early Immune Responses to Vaccination - A Substudy to HVTN 205

NCT00908323 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 47

Last updated 2021-10-15

No results posted yet for this study

Summary

HVTN 908 is a sub study of the HIV vaccine trial, HVTN 205. The purpose of this sub study is to better understand how a person's immune system responds to vaccines, particularly HIV vaccines. More specifically, researchers will determine whether early responses in the immune system help predict strong and long-lasting immunity.

Conditions

  • HIV Infections

Interventions

BIOLOGICAL

JS7 DNA vaccine

BIOLOGICAL

MVA/HIV62 vaccine

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Erica Andersen-Nissen, PhD · Fred Hutchinson Cancer Center

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00908323 on ClinicalTrials.gov